Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $5.7 million.

  • iSpecimen's Total Current Liabilities fell 909.19% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 909.19%. This contributed to the annual value of $5.8 million for FY2024, which is 460.42% down from last year.
  • iSpecimen's Total Current Liabilities amounted to $5.7 million in Q3 2025, which was down 909.19% from $5.2 million recorded in Q2 2025.
  • iSpecimen's Total Current Liabilities' 5-year high stood at $6.3 million during Q3 2024, with a 5-year trough of $2.0 million in Q2 2022.
  • Its 5-year average for Total Current Liabilities is $4.3 million, with a median of $4.6 million in 2022.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 8868.17% in 2021, then soared by 10325.32% in 2024.
  • Over the past 5 years, iSpecimen's Total Current Liabilities (Quarter) stood at $2.5 million in 2021, then soared by 70.87% to $4.3 million in 2022, then soared by 41.29% to $6.0 million in 2023, then fell by 4.6% to $5.8 million in 2024, then decreased by 1.25% to $5.7 million in 2025.
  • Its Total Current Liabilities was $5.7 million in Q3 2025, compared to $5.2 million in Q2 2025 and $4.9 million in Q1 2025.